Disclaimers

1. MEDICAL DISCLAIMER

THE SERVICES PROVIDED BY SLEEP DOCTOR ARE NOT A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE, DIAGNOSIS, TREATMENT, PSYCHOTHERAPY, COUNSELING, OR PHYSICAL OR MENTAL HEALTH SERVICES. ALL INFORMATION PROVIDED BY SLEEP DOCTOR IS FOR INFORMATIONAL PURPOSES ONLY, AND YOU HEREBY ASSUME ALL OF THE RISK IN USING SLEEP DOCTOR ’S SERVICES, INCLUDING BY WAY OF EXAMPLE AND NOT LIMITATION, ANY RISKS THAT MAY ARISE FROM THE SLEEP DOCTOR ’S NEGLIGENCE. SLEEP DOCTOR STRONGLY ADVISES THAT YOU SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH PROVIDER WITH ANY QUESTIONS YOU MAY HAVE REGARDING A MEDICAL CONDITION. NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE BECAUSE OF INFORMATION RECEIVED FROM SLEEP DOCTOR.

IF YOU BELIEVE YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR, GO TO YOUR LOCAL EMERGENCY ROOM, OR CALL THE LOCAL EMERGENCY PHONE NUMBER SUPPORTED BY GOVERNMENTAL AUTHORITIES (EXAMPLE 911 IN THE UNITED STATES) IMMEDIATELY.

WE DO NOT EXAMINE, DETERMINE, OR WARRANT THE COMPETENCE OF ANY HEALTH CARE PROVIDER OR ANY OTHER TYPE OF SERVICE PROVIDER LISTED ON THIS SITE. WE DO NOT WARRANT THAT THE HEALTH CARE PROVIDERS OR ANY OTHER TYPE OF SERVICE PROVIDERS LISTED ON THE SITE ARE CURRENTLY OR PROPERLY LICENSED. UNDER NO CIRCUMSTANCES SHOULD THIS SITE BE USED TO VERIFY THE CREDENTIALS OF MEDICAL PROVIDERS OR ANY OTHER TYPE OF SERVICE PROVIDERS. WE DO NOT RECOMMEND OR ENDORSE ANY SPECIFIC TESTS, PRODUCTS, PROCEDURES OR TREATMENTS, AND WE DO NOT RECOMMEND OR ENDORSE ANY INDIVIDUAL HEALTHCARE PROFESSIONAL OR TREATMENT REGIMEN. YOUR RELIANCE ON ANY INFORMATION AVAILABLE THROUGH THIS SITE OR IN THE MATERIALS IS SOLELY AT YOUR OWN RISK.

ON BEHALF OF YOUR EXECUTORS, ADMINISTRATORS, HEIRS, NEXT OF KIN, SUCCESSORS, AND ASSIGNS, YOU HEREBY: (A) WAIVE, RELEASE, AND DISCHARGE FROM ANY AND ALL LIABILITY FOR YOUR DEATH, DISABILITY, PERSONAL INJURY, PROPERTY DAMAGE, PROPERTY THEFT, OR ACTIONS OF ANY KIND WHICH MAY HEREAFTER OCCUR TO YOU, THE FOLLOWING ENTITIES OR PERSONS: SLEEP DOCTOR , ITS AFFILIATED ENTITIES, ITS AND THEIR DIRECT AND INDIRECT OWNERS, AND EACH OF ITS AND THEIR DIRECTORS, OFFICERS, EMPLOYEES, VOLUNTEERS, REPRESENTATIVES, AND AGENTS; AND (B) INDEMNIFY, HOLD HARMLESS, AND PROMISE NOT TO SUE THE ENTITIES OR PERSONS MENTIONED ABOVE FROM ANY AND ALL LIABILITIES OR CLAIMS MADE AS A RESULT OF YOUR USE OF SLEEP DOCTOR ’S SERVICES. THIS RELEASE SHALL BE CONSTRUED BROADLY TO PROVIDE A RELEASE AND WAIVER TO THE MAXIMUM EXTENT PERMISSIBLE UNDER APPLICABLE LAW.

2. WatchPAT One/HSAT

A portable, disposable type III home sleep apnea test (WatchPAT One®) was undertaken for a single sleep period. Although this type of test is limited compared to a type I attended in-lab laboratory polysomnogram (PSG) study for detecting sleep-related breathing disorders, it can be useful in carefully selected patients using standards defined by the American Academy of Sleep Medicine (AASM). This includes uncomplicated adult patients presenting with signs and symptoms that indicate an increased risk of moderate to severe OSA.  Some insurance providers stipulate that home sleep apnea testing is the initial diagnostic tool eligible for coverage regardless of the patient’s symptoms, risk factors, or comorbidities. This test is not appropriate for evaluating any sleep disorders other than sleep-related breathing disorders.  

A negative home sleep apnea test does not exclude the possibility of sleep apnea.  Similarly, there is a non-zero risk for a false positive result.  If sleep apnea is demonstrated, the severity defined by current AHI standards may be underestimated or overestimated.  AASM standard of practice states that if a single home sleep apnea test is negative, inconclusive, or technically inadequate, polysomnography is recommended to confirm or refute the diagnosis of OSA. Further, it is recommended that polysomnography, rather than home sleep apnea testing, be used for the diagnosis of OSA in patients with significant cardiorespiratory disease, potential respiratory muscle weakness due to neuromuscular condition, awake hypoventilation or suspicion of sleep-related hypoventilation, chronic opioid medication use, history of stroke or severe insomnia. 

References:  

Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017 Mar 15;13(3):479-504. doi: 10.5664/jcsm.6506. PMID: 28162150; PMCID: PMC5337595.

Rosen IM, Kirsch DB, Chervin RD, Carden KA, Ramar K, Aurora RN, Kristo DA, Malhotra RK, Martin JL, Olson EJ, Rosen CL, Rowley JA, American Academy of Sleep Medicine Board of Directors. Clinical use of a home sleep apnea test: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2017;13(10):1205–1207.

WatchPAT recording details:

Data collected from the device consists of PAT signal, pulse rate, oximetry, actigraphy, snoring, body position, chest motion. Scalp EEG, EOG, chin or limb EMG and airflow are not recorded with this device. The WatchPAT generates a PAT respiratory disturbance index (pRDI), PAT ApneaHypopnea Index (pAHI), PAT central Apnea-Hypopnea Index (pAHIc), percentage of total sleep time with Cheyne-Stokes Respiration pattern (p%CSR) and PAT sleep staging identification (pSTAGES). The WatchPAT also generates acoustic decibel detector used for snoring level and body position discrete states from the chest sensor. The WatchPAT respiratory indices and sleep stages are estimates of conventional values and sleep stage identification that are produced by Type I polysomnography (PSG). WatchPAT 300 provides a validated auto-scored report and raw data for manual review and editing capability for professional interpretation by a board-certified sleep medicine physician. Reported parameters and scoring of events captured during this recording is in accordance with The AASM Manual for the Scoring of Sleep and Associated Events, version 3, 2023.  Hypopneas were scored using the definition of the acceptable (1B, or CMS) hypopnea rule as described in The AASM Manual.

3. Disclaimer of Warranties

EXCEPT AS OTHERWISE EXPRESSLY PROVIDED IN THIS AGREEMENT, (A) THE SITE IS PROVIDED “AS-IS” AND “WITH ALL FAULTS”, AND, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, SLEEP DOCTOR, INCLUDING ITS AFFILIATES, SUBSIDIARIES, LICENSORS, SUBCONTRACTORS, DISTRIBUTORS, SERVICES PARTNERS, AGENTS AND MARKETING PARTNERS) AND EACH OF THEIR RESPECTIVE EMPLOYEES, DIRECTORS AND OFFICERS (COLLECTIVELY, THE “SLEEP DOCTOR PARTIES”) DISCLAIM ALL REPRESENTATIONS, WARRANTIES AND CONDITIONS OF ANY KIND, EXPRESS OR IMPLIED, REGARDING THE SITE, OR OTHERWISE RELATING TO THIS AGREEMENT, INCLUDING NON-INFRINGEMENT AND ACCURACY; (B) NEITHER SLEEP DOCTOR NOR ANY SLEEP DOCTOR PARTY WARRANTS THAT THE SITE IS OR WILL BE SECURE, ACCURATE, COMPLETE, UNINTERRUPTED, WITHOUT ERROR, OR FREE OF VIRUSES, WORMS, OTHER HARMFUL COMPONENTS, OR OTHER PROGRAM LIMITATIONS; (C) YOU ASSUME THE ENTIRE COST OF ALL NECESSARY SERVICING, REPAIR, OR CORRECTION OF PROBLEMS CAUSED BY VIRUSES OR OTHER HARMFUL COMPONENTS, UNLESS SUCH ERRORS OR VIRUSES ARE THE DIRECT RESULT OF SLEEP DOCTOR’S GROSS NEGLIGENCE OR WILLFUL MISCONDUCT; (D) SLEEP DOCTOR AND THE SLEEP DOCTOR PARTIES, JOINTLY AND SEVERALLY, DISCLAIM AND MAKE NO WARRANTIES OR REPRESENTATIONS AS TO THE ACCURACY, QUALITY, RELIABILITY, SUITABILITY, COMPLETENESS, USEFULNESS, OR EFFECTIVENESS OF THE INFORMATION OBTAINED, GENERATED OR OTHERWISE RECEIVED BY YOU FROM ACCESSING AND/OR USING THE SITE OR OTHERWISE RELATING TO THIS AGREEMENT, AND (E) USE OF THE SITE IS ENTIRELY AT YOUR OWN RISK AND NEITHER SLEEP DOCTOR NOR ANY OF THE SLEEP DOCTOR PARTIES SHALL HAVE ANY LIABILITY OR RESPONSIBILITY THEREFOR.

4. Community Disclaimer

We highly encourage all customers with special needs to register with their state's special needs registry to ensure timely and appropriate assistance in the event of an emergency. The statewide registry provides first responders with valuable information to prepare for disasters or other emergencies.

Last updated: December 11, 2024